Royce & Associates’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-7,412
| Closed | -$57K | – | 1217 |
|
|
2020
Q2 | $57K | Sell |
7,412
-9,524
| -56% | -$73.2K | ﹤0.01% | 1025 |
|
|
2020
Q1 | $105K | Sell |
16,936
-179,736
| -91% | -$1.11M | ﹤0.01% | 969 |
|
|
2019
Q4 | $2.39M | Sell |
196,672
-99,126
| -34% | -$1.21M | 0.02% | 666 |
|
|
2019
Q3 | $3.42M | Sell |
295,798
-263,509
| -47% | -$3.04M | 0.03% | 580 |
|
|
2019
Q2 | $5.59M | Sell |
559,307
-155,150
| -22% | -$1.55M | 0.05% | 465 |
|
|
2019
Q1 | $9.2M | Buy |
714,457
+47,553
| +7% | +$612K | 0.08% | 357 |
|
|
2018
Q4 | $10.1M | Buy |
666,904
+582,135
| +687% | +$8.84M | 0.09% | 314 |
|
|
2018
Q3 | $1.7M | Buy |
84,769
+83,890
| +9,544% | +$1.68M | 0.01% | 856 |
|
|
2018
Q2 | $17K | Buy |
879
+266
| +43% | +$5.14K | ﹤0.01% | 1157 |
|
|
2018
Q1 | $12K | Sell |
613
-246
| -29% | -$4.82K | ﹤0.01% | 1156 |
|
|
2017
Q4 | $11K | Buy |
859
+284
| +49% | +$3.64K | ﹤0.01% | 1172 |
|
|
2017
Q3 | $11K | Buy |
+575
| New | +$11K | ﹤0.01% | 1157 |
|
|
2015
Q4 | – | Sell |
-19,900
| Closed | -$791K | – | 1203 |
|
|
2015
Q3 | $791K | Buy |
+19,900
| New | +$791K | ﹤0.01% | 993 |
|